Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
2
Neutral
5
Bullish
7
Bearish
30
Neutral
5
Bullish
11
Bearish
28
Neutral
0
Bullish
4
Discovery themes featuring this stock
Medi-caps Ltd., founded in 1983, is the second-largest manufacturer of empty hard gelatine capsules in India, serving major pharmaceutical companies for oral medications.
The company achieved notable manufacturing milestones, including zero-defect production and full operation normalization, reflecting its industry expertise and quality control.
Medi-caps discontinued its capsule production in 2019 and has transitioned into real estate with the Medicaps Business Park project initiated in partnership with Tirupati Reality & Developers.
Historically, the company expanded its manufacturing capabilities significantly and entered the export markets of several countries, showcasing its previous industry reach.
The company's foray into real estate marks a transformative shift from its pharmaceutical manufacturing origins, indicating strategic diversification.
Pharmaceuticals & Biotechnology
Pharmaceuticals
34 Cr
Moderate Risk
-11.0
34.3
—
0.3
46.99
21.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
41.61 | 40 Cr | 25.77 | 1.20 | 1.92 | 3.69 | 5.32 | 2.80 | ||
46.65 | 37 Cr | 465.00 | 2.11 | 0.00 | 23.13 | 15.39 | 0.11 | ||
7.15 | 36 Cr | -1.05 | 0.72 | 0.00 | -26.30 | -22.21 | -51.43 | ||
26.97 | 34 Cr | -11.04 | 0.30 | 0.00 | -2.72 | -2.70 | -2.63 | ||
0.27 | 33 Cr | -1.96 | 0.34 | 0.00 | -5.66 | -5.66 | -3.33 | ||
43.90 | 33 Cr | 10.86 | 1.00 | 0.00 | 9.20 | 12.30 | 3.24 | ||
33.90 | 29 Cr | 7.82 | 1.18 | 0.00 | 20.15 | 30.12 | 10.11 | ||
| Median: 7 Co. | — | 33.90 | 34 Cr | 7.82 | 1.00 | 0.00 | 3.69 | 5.32 | 0.11 |
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Medi Caps Ltd (MEDICAPS) is currently trading at 26.97 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Medi-caps Ltd., founded in 1983, is the second-largest manufacturer of empty hard gelatine capsules in India, serving major pharmaceutical companies for oral medications. The company achieved notable manufacturing milestones, including zero-defect production and full operation normalization, reflecting its industry expertise and quality control. Medi-caps discontinued its capsule production in 2019 and has transitioned into real estate with the Medicaps Business Park project initiated in partnership with Tirupati Reality & Developers. Historically, the company expanded its manufacturing capabilities significantly and entered the export markets of several countries, showcasing its previous industry reach. The company's foray into real estate marks a transformative shift from its pharmaceutical manufacturing origins, indicating strategic diversification.
Over the past 52 weeks, Medi Caps Ltd has traded between a low of ₹21.00 and a high of ₹46.99. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Medi Caps Ltd has a market capitalization of approximately 33.57. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Medi Caps Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -11.04 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 33.57 Cr, Medi Caps Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Medi Caps Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Medi Caps Ltd is -11.04. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
